A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer

Clinical trial NCT02391480 · COMPLETED

Trial details

NCT number: NCT02391480
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Breast Cancer Non-Small Cell Lung Cancer Acute Myeloid Leukemia (AML)Multiple Myeloma Prostate Cancer Small Cell Lung Cancer Non-Hodgkins Lymphoma

Start date: 2015-04-14
Primary completion: 2019-07-05
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.